CURAE PHARMA360 Trademark

Trademark Overview

On Friday, March 11, 2022, a trademark application was filed for CURAE PHARMA360 with the United States Patent and Trademark Office. The USPTO has given the CURAE PHARMA360 trademark a serial number of 97307620. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, November 19, 2024. This trademark is owned by Curae Pharma360 Inc.. The CURAE PHARMA360 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer

General Information

Serial Number97307620
Word MarkCURAE PHARMA360
Filing DateFriday, March 11, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements

Description of MarkThe mark consists of the stylized wording CURAE in cursive lettering with the wording PHARMA360 underneath.
Goods and ServicesPharmaceutical products for the treatment of cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCurae Pharma360 Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWILMINGTON, DE 19801
Party NameCurae Pharma360 Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105

Trademark Events

Event DateEvent Description
Tuesday, March 15, 2022NEW APPLICATION ENTERED
Wednesday, March 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 22, 2022ASSIGNED TO EXAMINER
Tuesday, January 3, 2023SUSPENSION LETTER WRITTEN
Tuesday, January 3, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, January 3, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 8, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 8, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 3, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, July 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 28, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 28, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 2, 2024SOU EXTENSION 1 FILED
Wednesday, October 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 20, 2024SOU EXTENSION 1 GRANTED
Wednesday, November 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

pharma curae cancer treatment products pharmaceutical